Literature DB >> 12393592

Platelet activation induced by human antibodies to interleukin-8.

Veronique Regnault1, Emmanuel de Maistre, Jean-Pierre Carteaux, Yves Gruel, Philippe Nguyen, Brigitte Tardy, Thomas Lecompte.   

Abstract

Some cases of heparin-induced thrombocytopenia (HIT) have been reported to be associated with antibodies against interleukin-8 (IL-8), a chemokine related to platelet factor 4. We found that sera from 5 HIT patients containing immunoglobulin G (IgG) or IgM antibodies to IL-8, as evidenced using surface plasmon resonance spectroscopy, were able to trigger IL-8-dependent activation of washed platelets, leading to procoagulant activity. This activation occurred at IL-8 concentrations achievable in vivo and was facilitated by heparin (0.1 U/mL). Activation was also induced by affinity-purified anti-IL-8 IgG and involved FcgammaRIIa. In the 2 patients who could be followed up, antibodies were no longer detectable 4 months after heparin withdrawal. One additional patient with paraneoplastic recurrent thrombosis without thrombocytopenia was found to have platelet-activating anti-IL-8 IgM, but in this case heparin was inhibitory. This is another example of potentially pathogenic platelet activation by antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393592     DOI: 10.1182/blood-2002-02-0620

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.

Authors:  Tamam Bakchoul; Andreas Greinacher
Journal:  Ther Adv Hematol       Date:  2012-08

2.  High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.

Authors:  Igor F Domingos; Diego A Pereira-Martins; Marcondes J V C Sobreira; Romulo T D Oliveira; Adekunle E Alagbe; Carolina Lanaro; Dulcineia M Albuquerque; Maria H S L Blotta; Aderson S Araujo; Fernando F Costa; Antonio R Lucena-Araujo; Maria F Sonati; Marcos A C Bezerra; Magnun N N Santos
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

Review 3.  The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.

Authors:  Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Gabriel Pasquarelli-do-Nascimento; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Med (Lausanne)       Date:  2021-04-23

4.  Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.

Authors:  Marsha S Russell; Marybeth Creskey; Abenaya Muralidharan; Changgui Li; Jun Gao; Wangxue Chen; Louise Larocque; Jessie R Lavoie; Aaron Farnsworth; Michael Rosu-Myles; Anwar M Hashem; Carole L Yauk; Jingxin Cao; Gary Van Domselaar; Terry Cyr; Xuguang Li
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 5.  Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.

Authors:  Brigitte Tardy; Thomas Lecompte; François Mullier; Caroline Vayne; Claire Pouplard
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

6.  Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia.

Authors:  Shuo Zhang; Jingge Qu; Li Wang; Mengtao Li; Dong Xu; Yan Zhao; Fengchun Zhang; Xiaofeng Zeng
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

Review 7.  Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?

Authors:  Mehran Ghasemzadeh; Javad Ahmadi; Ehteramolsadat Hosseini
Journal:  Thromb Res       Date:  2022-03-31       Impact factor: 10.407

8.  Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.

Authors:  Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

9.  Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.

Authors:  Junhong Wang; Hua Zhang; Rui Qiao; Qinggang Ge; Shuisheng Zhang; Zongxuan Zhao; Ci Tian; Qingbian Ma; Ning Shen
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

Review 10.  Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches.

Authors:  Panagiotis Theofilis; Marios Sagris; Evangelos Oikonomou; Alexios S Antonopoulos; Konstantinos Tsioufis; Dimitris Tousoulis
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.